Showing results (611-620 of 637) with videos related to
Sort By:
Pageof 64
Oncogene|September 4, 2019
Cellular prion protein transcriptionally regulated by NFIL3 enhances lung cancer cell lamellipodium formation and migration through JNK signalingShin-Chih Lin, Chia-Hung Lin, Nien-Chu Shih, et al.Plos One|June 18, 2015
Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous MetaplasiaHongfei Ge, Jonitha Gardner, Xiaosu Wu, et al.Nature Communications|June 1, 2021
Development of selective bispecific Wnt mimetics for bone loss and repairTristan W Fowler, Troy L Mitchell, Claudia Y Janda, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2018
Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort AnalysisSarina Bains, Takashi Eguchi, Arne Warth, et al.Nature Communications|June 2, 2023
Therapeutic blood-brain barrier modulation and stroke treatment by a bioengineered FZDJie Ding, Sung-Jin Lee, Lukas Vlahos, et al.Cellular and Molecular Gastroenterology and Hepatology|May 15, 2022
Robust Colonic Epithelial Regeneration and Amelioration of Colitis via FZD-Specific Activation of Wnt SignalingLiqin Xie, Russell B Fletcher, Diksha Bhatia, et al.Journal for Immunotherapy of Cancer|April 3, 2020
PRKDC: new biomarker and drug target for checkpoint blockade immunotherapyKien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, et al.Cell Chemical Biology|July 6, 2023
Novel Frizzled-specific antibody-based Wnt mimetics and Wnt superagonists selectively activate WNT/β-catenin signaling in target tissuesYorick Post, Archana Dilip, Liqin Xie, et al.The American Journal of Surgical Pathology|May 13, 2022
Targeted Next-generation Sequencing Reveals a Wide Morphologic and Immunophenotypic Spectrum of Monomorphic Epitheliotropic Intestinal T-Cell LymphomaJen-Fan Hang, Chang-Tsu Yuan, Kung-Chao Chang, et al.Allergy and Asthma Proceedings|September 3, 2021
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitisGayatri B Patel, Elizabeth A Kudlaty, Amina Guo, et al.Pageof 64